Sign in

CIK 0001501989 · Accelerated filer

CytomX Therapeutics, Inc.

Sign in to watch
Ticker
CTMX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
273521219
Phone
650.515.3185
Business address
151 OYSTER POINT BLVD., SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2015-10-14 Flynn James E 10% owner Conversion · Series D Convertible Preferred Stock −160,512 0
2015-10-14 Flynn James E 10% owner Conversion · Series D Convertible Preferred Stock −160,512 0
2015-10-14 Hadley Harbor Master Investors (Cayman) L.P. 10% owner Conversion +749,055 749,055
2015-10-14 Hadley Harbor Master Investors (Cayman) L.P. 10% owner Conversion · Series D Convertible Preferred Stock −749,055 0
2015-10-07 Young Matthew P. Director Grant or award · Stock Option (right to buy) +26,985 26,985
2015-08-26 LADD CYNTHIA J Senior VP and General Counsel Grant or award · Employee Stock Option (right to buy) +27,393 27,393
2015-08-26 Kavanaugh William Michael CSO, Head Res.&Non-Clin. Dev. Grant or award · Emploiyee Stock Option (right to buy) +85,605 85,605
2015-07-21 LADD CYNTHIA J Senior VP and General Counsel Grant or award · Employee Stock Option (right to buy) +246,043 246,043
2015-05-07 Kavanaugh William Michael CSO, Head Res.&Non-Clin. Dev. Grant or award · Employee Stock Option (right to buy) +246,042 246,042

Page 33 of 33 · 649 trades